ATE527272T1 - Synthese von triphenylphosphoniumchinolen und - chinonen - Google Patents

Synthese von triphenylphosphoniumchinolen und - chinonen

Info

Publication number
ATE527272T1
ATE527272T1 AT02760924T AT02760924T ATE527272T1 AT E527272 T1 ATE527272 T1 AT E527272T1 AT 02760924 T AT02760924 T AT 02760924T AT 02760924 T AT02760924 T AT 02760924T AT E527272 T1 ATE527272 T1 AT E527272T1
Authority
AT
Austria
Prior art keywords
quinones
sub
triphenylphosphoniumquinoles
synthesis
typified
Prior art date
Application number
AT02760924T
Other languages
English (en)
Inventor
Robin Smith
Michael Murphy
Original Assignee
Antipodean Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antipodean Pharmaceuticals Inc filed Critical Antipodean Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE527272T1 publication Critical patent/ATE527272T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fireproofing Substances (AREA)
AT02760924T 2001-08-13 2002-08-12 Synthese von triphenylphosphoniumchinolen und - chinonen ATE527272T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ513547A NZ513547A (en) 2001-08-13 2001-08-13 Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone)
PCT/NZ2002/000154 WO2003016323A1 (en) 2001-08-13 2002-08-12 Synthesis of triphenylphosphonium quinols snd quinones

Publications (1)

Publication Number Publication Date
ATE527272T1 true ATE527272T1 (de) 2011-10-15

Family

ID=19928579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02760924T ATE527272T1 (de) 2001-08-13 2002-08-12 Synthese von triphenylphosphoniumchinolen und - chinonen

Country Status (5)

Country Link
US (1) US7179928B2 (de)
EP (1) EP1423396B1 (de)
AT (1) ATE527272T1 (de)
NZ (1) NZ513547A (de)
WO (1) WO2003016323A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080275005A1 (en) * 1998-11-25 2008-11-06 Murphy Michael P Mitochondrially targeted antioxidants
US20060229278A1 (en) * 1998-11-25 2006-10-12 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
US7888334B2 (en) 2003-08-22 2011-02-15 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
KR101003960B1 (ko) * 2003-08-22 2010-12-30 안티포딘 파마슈티칼스, 인코포레이티드 미토콘드리아 표적화 산화방지제로서 사용되는 미토퀴논 유도체를 포함하는 약제학적 조성물
AU2004266988B2 (en) * 2003-08-22 2011-05-26 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
AU2005261654A1 (en) * 2004-07-13 2006-01-19 Oridis Biomed Forschungs- Und Entwicklungs Gmbh Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers
EA035619B1 (ru) 2005-06-01 2020-07-16 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Композиции для использования в способе лечения митохондриальных нарушений
JP2009508867A (ja) * 2005-09-15 2009-03-05 エジソン ファーマシューティカルズ, インコーポレイテッド ミトコンドリア病および関連した様態の治療ならびにエネルギーバイオマーカーの調節のための酸化還元活性治療剤のテイル改変体
EP1986636B1 (de) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol- und 1,4-benzochinon-derivate zur verwendung in der behandlung von erkrankungen der mitochondrien
EP2332534B1 (de) 2006-02-22 2018-11-14 Bioelectron Technology Corporation Phenol- und Benzoquinonederivate zur Verwendung in der Behandlung von Mitochondriopathien und zur Modulation von Energie-Biomarkern
WO2008086025A2 (en) * 2007-01-10 2008-07-17 Edison Pharmaceuticals, Inc. Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity
PL2220030T3 (pl) 2007-11-06 2016-07-29 Bioelectron Tech Corp Pochodne 4-(p-chinonylo)-2-hydroksybutanamidu do leczenia chorób mitochondrialnych
EP2237664A4 (de) 2008-01-08 2013-05-22 Edison Pharmaceuticals Inc (HET) ARYL-p-CHINONDERIVATE ZUR BEHANDLUNG MITOCHONDRIALER ERKRANKUNGEN
WO2009111576A2 (en) 2008-03-05 2009-09-11 Edison Pharmaceuticals, Inc. 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
WO2009143268A2 (en) * 2008-05-22 2009-11-26 Edison Pharmaceuticals, Inc. Treatment of mitochondrial diseases with an erythropoietin mimetic
EP2303824B1 (de) * 2008-06-25 2015-03-25 Edison Pharmaceuticals, Inc. 2-heterocyclylaminoalkyl-(p-chinon)-derivate zur behandlung von krankheiten mit oxidativem stress
EP2344142B1 (de) 2008-09-10 2024-06-26 PTC Therapeutics, Inc. Behandlung von pervasiven entwicklungsstörungen mit redox-aktiven therapeutika
KR102020579B1 (ko) 2011-04-26 2019-09-10 레트로토프 인코포레이티드 에너지 프로세싱 손상 장애 및 미토콘드리아 결함
US10058522B2 (en) 2011-04-26 2018-08-28 Retrotope, Inc. Oxidative retinal diseases
WO2012148929A2 (en) 2011-04-26 2012-11-01 Retrotope, Inc. Disorders implicating pufa oxidation
US10154983B2 (en) 2011-04-26 2018-12-18 Retrotope, Inc. Neurodegenerative disorders and muscle diseases implicating PUFAs
KR102137450B1 (ko) 2012-07-12 2020-07-27 콘드리온 아이피 비.브이. 미토콘드리아 질환을 치료하기 위한 크로마닐 유도체
CA2883879A1 (en) 2012-09-07 2014-03-13 Edison Pharmaceuticals, Inc. Quinone derivatives for use in the modulation of redox status of individuals
US9670170B2 (en) 2013-03-15 2017-06-06 Bioelectron Technology Corporation Resorufin derivatives for treatment of oxidative stress disorders
US20140275045A1 (en) 2013-03-15 2014-09-18 Edison Pharmaceuticals, Inc. Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
JP2016515526A (ja) 2013-03-15 2016-05-30 エジソン ファーマシューティカルズ, インコーポレイテッド 酸化ストレス障害の処置のためのアルキル−ヘテロアリール置換されたキノン誘導体
US9868711B2 (en) 2013-03-15 2018-01-16 Bioelectron Technology Corporation Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US9296712B2 (en) 2013-03-15 2016-03-29 Edison Pharmaceuticals, Inc. Resorufin derivatives for treatment of oxidative stress disorders
WO2014194292A1 (en) 2013-05-31 2014-12-04 Edison Pharmaceuticals, Inc. Carboxylic acid derivatives for treatment of oxidative stress disorders
AU2015229240B9 (en) 2014-03-13 2019-05-02 Biojiva Llc Optic neuropathy treatment and reduction of steroid-induced oxidative stress with stabilized polyunsaturated substances
US9314457B2 (en) 2014-06-19 2016-04-19 The University Of Utah Research Foundation Methods of treating and preventing vascular instability diseases
HUE058877T2 (hu) 2014-12-16 2022-09-28 Ptc Therapeutics Inc (R)-2-hidroxi-2-metil-4-(2,4,5-trimetil-3,6-dioxociklohexa-1,4-dienil)butánamid polimorf és amorf alakjai
ES3033538T3 (en) 2015-10-08 2025-08-05 Khondrion Ip B V Novel compounds for treating mitochondrial disease
EP3389646A1 (de) 2015-12-17 2018-10-24 BioElectron Technology Corporation Flouralkyl, flouralkoxy, phenoxy, heteroaryloxy, alkoxy und amin-1,4-benzochinon-derivate zur behandlung von oxidativen stresserkrankungen
WO2018094116A1 (en) 2016-11-17 2018-05-24 Retrotope, Inc. Isotopically modified components and therapeutic uses thereof
WO2018129411A1 (en) 2017-01-06 2018-07-12 Bioelectron Technology Corporation Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders
CN109793720B (zh) * 2019-01-28 2022-01-14 温州医科大学 一种基于透明质酸的线粒体靶向抗氧化剂Mito Q纳米制剂的制备方法及应用
WO2020252414A1 (en) 2019-06-13 2020-12-17 Ptc Therapeutics, Inc. Naphthoquinone derivatives for treatment of oxidative stress disorders
CA3164800A1 (en) 2019-12-16 2021-06-24 Unist(Ulsan National Institute Of Science And Technology) Compound for inhibiting neovascularization factors and use thereof
WO2022019362A1 (ko) * 2020-07-24 2022-01-27 울산과학기술원 Tpp 유도체 화합물 및 이를 포함하는 노화 또는 노화 관련 질환의 치료 또는 예방을 위한 약학적 조성물
US11389431B2 (en) 2020-09-09 2022-07-19 Social Profit Network Methods and compositions for delivery of biotin to mitochondria
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS
US11491130B2 (en) 2021-02-05 2022-11-08 Retrotope, Inc. Methods of treating amyotrophic lateral sclerosis
WO2026008715A1 (en) 2024-07-02 2026-01-08 Université Catholique de Louvain Mitochondrially-targeted antioxidant compound for use in radiation therapy
CN118994239B (zh) * 2024-08-09 2025-09-26 苏州满元生物科技有限公司 氧化制备米托醌的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0237338B2 (ja) 1982-08-27 1990-08-23 Takeda Chemical Industries Ltd 99*3*44jimetokishii22hidorokishii66mechirubenzoiru*nonanoeetonoseizoho
ES2051841T3 (es) 1987-04-27 1994-07-01 Takeda Chemical Industries Ltd Reduccion de esteres carboxilicos.
JPH07223991A (ja) 1993-12-17 1995-08-22 Takeda Chem Ind Ltd アシル置換芳香族化合物の製造法
JP2637705B2 (ja) 1995-03-02 1997-08-06 株式会社ナード研究所 ベンゾキノン系誘導体の製造法
US6331532B1 (en) * 1998-11-25 2001-12-18 University Of Otago Mitochondrially targeted antioxidants

Also Published As

Publication number Publication date
WO2003016323A1 (en) 2003-02-27
EP1423396A1 (de) 2004-06-02
EP1423396A4 (de) 2006-02-22
NZ513547A (en) 2002-09-27
EP1423396B1 (de) 2011-10-05
US20050043553A1 (en) 2005-02-24
US7179928B2 (en) 2007-02-20

Similar Documents

Publication Publication Date Title
EP1423396A4 (de) Synthese von triphenylphosphoniumchinolen und -chinonen
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
DE60012188D1 (de) Fungizide
GT200000103A (es) Trifluorbutenos nematocidas.
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
RU96119782A (ru) Производные 7-амино-1h-индола
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
CY1109593T1 (el) Παραγωγα 12,13-κυκλοπροπανο εποθιλονης
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY1113657T1 (el) Νεα παραγωγα βενζοφαινονης ή αλατα αυτων
AR066694A2 (es) Metodo para la preparacion de citalopram
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
DK1385514T5 (da) Spiroinden- og spiroindanforbindelser
CY1109276T1 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
ATE288900T1 (de) Substituierte benzoylcyclohexandione
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
AR030505A1 (es) Proceso para la preparacion de fenilacetronitrilos sustituidos
EA199900790A1 (ru) Способы получения пестицидных промежуточных соединений
DE60123034D1 (de) Herstellung von sekundären aminoisobutylalkoxysilanen
EA200100129A1 (ru) Способ получения гидроксиметилтиобутановой кислоты
TR200402547T4 (tr) Pantoprazol ve ara maddelerini hazırlamak için bir işlem.
ES2055503T3 (es) Diimida de silicio y procedimiento para su fabricacion, y para la fabricacion de nitruro de silicio generado a partir de la misma.
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties